AC Partners (ACPS) 10-K 31 Mar 15 2014 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (HUF)	12 Months Ended
	Dec. 31, 2014
Document And Entity Information
Entity Registrant Name	iGlue, Inc.
Entity Central Index Key	1133116
Document Type	10-K
Document Period End Date	31-Dec-14
Amendment Flag	FALSE
Current Fiscal Year End Date	-19
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float	4,558,240
Entity Common Stock, Shares Outstanding	11,995,370
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2014

Balance_Sheet

Balance Sheet (USD $)	Dec. 31, 2014	Dec. 31, 2013
Current Assets
Cash	$563	$3,636
Other receivables	18,873	26,023
Total Current Assets	19,436	29,659
Intangible assets, net	188	673
Fixed assets, net	233	515
Total Non-Current Assets	421	1,188
Total Assets	19,857	30,847
Current Liabilities
Accounts payable and accrued expenses	103,537	109,457
Note payable	750,000	750,000
Other liabilities	338,371	237,290
Total Current Liabilities	1,191,908	1,096,747
Stockholders' Deficit
Common stock, $0.11 par value; 11,919,370 and 11,919,370 shares issued and outstanding	1,311,131	1,311,131
Preferred stock, $0.001 par value 1,000,000 Series A issued and outstanding	1,000	1,000
Unearned compensation		96,000
Additional Paid-In Capital	9,661,926	9,661,926
Deficit accumulated during development stage	-12,251,834	-12,058,008
Other comprehensive income	105,726	114,051
Total Stockholders' Deficit	-1,172,051	-1,065,900
Total liabilities and stockholders' deficit	19,857	30,847
Series A Preferred Stock
Stockholders' Deficit
Preferred stock, $0.001 par value 1,000,000 Series A issued and outstanding	1,000	1,000
Total Stockholders' Deficit	1,000	1,000
Total liabilities and stockholders' deficit	$1,000	$1,000

Balance_Sheet_Parenthetical

Balance Sheet (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Common stock, par value per share	$0.11	$0.11
Common stock, shares issued	11,919,370	11,919,370
Common stock, shares outstanding	11,919,370	11,919,370
Series A Preferred Stock
Preferred stock, par value per share	$0.00	$0.00
Preferred stock, shares issued	1,000,000	1,000,000
Preferred stock, shares outstanding	1,000,000	1,000,000

Statements_Of_Operations

Statements Of Operations (USD $)	12 Months Ended		87 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014
Income Statement [Abstract]
Net Sales
Research and development			2,051,802
General administration	111,789	2,013,288	9,137,112
Operating expenses	111,789	2,013,288	11,188,914
Loss from operations	-111,789	-2,013,288	-11,188,914
Interest expenses and exchange gains	-82,037	-91,439	-302,920
Net loss	($193,826)	($2,104,727)	($11,491,834)
Basic loss per share	($0.02)	($0.18)
Weighted average number of shares outstanding - Basic and diluted	11,919,370	11,599,152

Statement_Of_Stockholders_Defi

Statement Of Stockholders' Deficit And Comprehensive Income (USD $)	Common Stock	Preferred Stock Series A	Preferred Stock Series B	Capital Receivable	Accumulated Deficit During Development Stage	Additional Paid In Capital	Unearned Compensation	Other Comprehensive Income	Total	Comprehensive Income/ (Loss)
Balance, value at Sep. 18, 2007
Issuance of common stock, value	$17,306								$17,306
Currency Translation Adjustment								-200	-200	-200
Net loss for the period					-47,733				-47,733	-47,733
Balance value at Dec. 31, 2007	17,306				-47,733			-200	-30,627	-47,933
Currency Translation Adjustment								24,653	24,653	24,653
Net loss for the period					-231,501				-231,501	-231,501
Balance value at Dec. 31, 2008	17,306				-279,234			24,453	-237,475	-206,848
Issuance of common stock, value	2,643					251,057			253,700
Currency Translation Adjustment								-15,742	-15,742	-15,742
Net loss for the period					-253,511				-253,511	-253,511
Balance value at Dec. 31, 2009	19,949				-532,745	251,057		8,711	-253,028	-269,253
Issuance of common stock, value	2,678			-666		594,483			596,495
Currency Translation Adjustment								66,173	66,173	66,173
Net loss for the period					-363,030				-363,030	-363,030
Balance value at Dec. 31, 2010	22,627			-666	-895,775	845,540		74,884	46,610	-296,857
Currency Translation Adjustment								-7,395	-7,395	-7,395
Recapitalisation under reverse merger, value	128,655					-128,655
Preferred stock		1,000	886			-1,886
Payment of advance on stock issue				666		609,241			609,907
Issue of convertible note for reverse merger (see Note 7)					-760,000				-760,000
Net loss for the period					-632,584				-632,584	-632,584
Balance value at Dec. 31, 2011	153,168				-2,288,359	1,324,240		67,489	-743,462	-639,979
Currency Translation Adjustment								46,972	46,972	46,972
Private placement of shares at $1 per share, value	12,790					103,485			116,275
Share based payment at $8 per share, value	13,420					962,580	-976,000
Share based payment at $9.25 per share,value	89,210					7,412,540	-7,501,750
Private placement of shares at $2 per share, value	1,245					21,379			22,624
Share based payment at $4 per share, value	22,000					858,000	-880,000
Issue of shares for advance payments	46,584					-46,584
Stock split	973,714					-973,714
Amortization of share based compensation							7,293,750		7,293,750
Net loss for the period					-7,664,922				-7,664,922	-7,664,922
Balance value at Dec. 31, 2012	1,312,131				-9,953,281	9,661,926	-2,064,000	114,461	-928,763	-7,617,950
Currency Translation Adjustment								-410	-410	-410
Amortization of share based compensation							1,968,000		1,968,000
Net loss for the period					-2,104,727				-2,104,727	-2,104,727
Balance value at Dec. 31, 2013	1,312,131				-12,058,008	9,661,926	-96,000	114,051	-1,065,900	-2,105,137
Currency Translation Adjustment								-8,325	-8,325	-8,325
Amortization of share based compensation							96,000		96,000
Net loss for the period					-193,826				-193,826	-193,826
Balance value at Dec. 31, 2014	$1,312,131				($12,251,834)	$9,661,926		$105,726	($1,172,051)	($202,151)

Statement_Of_Stockholders_Defi1

Statement Of Stockholders' Deficit And Comprehensive Income (Parenthetical) (USD $)	Dec. 31, 2012	Apr. 04, 2012
Stock price per share	$1	$2
Issuance Price - USD 8
Stock price per share	$8
Issuance Price - USD 9.25
Stock price per share	$9.25
Issuance Price - USD 4
Stock price per share	$4

Statements_Of_Cash_Flows

Statements Of Cash Flows (USD $)	12 Months Ended		87 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	($193,826)	($2,104,727)	($11,491,834)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest accrued	90,000	90,000	284,548
Stock based payments	96,000	1,968,000	9,357,750
Recapitalisation under reverse merger			-10,000
Depreciation and amortization	625	2,527	53,008
Changes in operating assets and liabilities:
(Increase) Decrease in other current assets	-7,150	-7,055	18,873
(Decrease) Increase in accounts payable other and accrued liabilities	5,303	40,540	157,502
Net cash used in operating activities	5,252	3,395	-1,667,899
CASH FLOWS FROM INVESTING ACTIVITIES
Acquisition of non-current assets			53,571
Net cash used in investing activities			-53,571
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from stockholders			1,616,307
Net cash from financing activities			1,616,307
Effect of exchange rate changes on cash	-8,325	-324	105,726
Net (decrease) increase in cash	-3,073	3,071	563
Cash at beginning of period	3,636	565
Cash at end of period	563	3,636	563
Supplemental disclosure of cash flow information:
Cash paid for Interest
Cash paid for Taxes

General_Information

General Information	12 Months Ended
	Dec. 31, 2014
General Information
General Information	NOTE 1 - GENERAL INFORMATION
	In4 Ltd. was incorporated in Budapest, Hungary on September 19, 2007, with the objective to develop Web 3.0 internet technologies based on natural language processing and semantic analysis The company is located at Soroksari út. 94-96, Budapest, 1095 Hungary. The Company was owned by 3 private individuals and by Power of the Dreams Ventures, Inc.
	Going Concern and Management’s Plan
	The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate the continuation of the Company as a going concern and assume realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred losses from operations since inception. Management anticipates incurring additional losses in 2012. Further, the Company may incur additional losses thereafter, depending on its ability to generate revenues from the licensing or sale of its technologies and products, or to enter into any or a sufficient number of joint ventures. The Company has no revenue to date.
	Since inception through December 31, 2014, the Company had an accumulated deficit of $12,251,834 and net cash used in operations of $1,667,899. However, management of the Company believes that the future funding from the private placement of the Company’s common shares will allow them to continue operations and execute its business plan.
	Reverse merger
	On November 3, 2011, the Company entered into a securities exchange agreement with Park Slope, LLC (the “Hardwired Majority Shareholder”), In4, Ltd., and all of the shareholders of In4 Ltd. On November 11, 2011, pursuant to the terms of the Exchange Agreement, the In4 Ltd shareholders transferred and contributed all of their shares to the Company, resulting in an acquisition of all of the outstanding In4 Ltd shares. In return, the Company issued to the In4 Ltd. shareholders, their designees or assigns, an aggregate of 1,000,000 shares of Series A convertible preferred stock, par value $0.001 per share of the Company (the “Series A Preferred Stock”), and 886,000 shares of Series B convertible preferred stock, par value $0.001 per share of the Company (the “Series B Preferred Stock”, and together with the Series A Preferred Stock the “Hardwired Exchange Shares”). The foregoing issuances of the Hardwired Exchange Shares to the In4 Ltd shareholders, their designees or assigns, constituted 100% of the issued and outstanding preferred stock of In4 Ltd. as of and immediately after the consummation of the transactions contemplated by the Exchange Agreement.
	Following the acquisition the former stockholders of In4 Ltd. owned a majority of the issued and outstanding common stock of iGlue, Inc. and the management of In4 Ltd. controlled the Board of Directors of iGlue, Inc. and its wholly-owned Hungarian subsidiary In4 Ltd. Therefore the acquisition has been accounted for as a reverse merger (the “Reverse Merger”) with In4 Ltd. as the accounting acquirer of iGlue. The Company has changed its prior name of Hardwired Inc. to iGlue, Inc. The accompanying consolidated financial statements of the Company reflect the historical results of In4 Ltd., and the consolidated results of operations of iGlue, Inc. subsequent to the acquisition date. In connection with the Exchange Agreement, iGlue, Inc. adopted the fiscal year end of In4 Ltd. as December 31.
	All reference to shares and per share amounts in the accompanying consolidated financial statements have been restated to reflect the aforementioned shares exchange.
	Reverse stock split
	On January 15, 2012 the Company performed a reverse stock split of 1:110, merging every 110 share to 1 resulting in a reduction of the issued and outstanding number shares from 151,282,223 to 1,375,293, with corresponding increase of par values from $0.001 to $0.11. All reference to shares and per share amounts in the accompanying consolidated financial statements have been retroactively restated to reflect the aforementioned reverse stock split.
	Business
	Through In4, the Company aims to build the world’s largest semantic micro-search and content organizer (curation) company based around our Award Winning iGlue software. The Company considers iGlue to be one of the first and major Web 3.0 initiatives currently under development
	The Company’s focus is to utilize iGlue’s natural language processing and semantic micro-search capabilities to bring value added content to words on web pages. Rather than doing a search to find more information on a given topic (word) the software brings value added multimedia information as presented in a pop-up window. Images, videos, text, geographic locations, tweets, links, etc. The Company’s strategy is to deploy iGlue across the internet as a standalone, free consumer facing product, and at the same time provide value added corporate versions based around a subscription based business model and advertising revenue sharing.
	The Company intends to provide iGlue in the following versions:
		·	free, consumer facing plug-in version;
		·	value added semantic advertising platform;
		·	corporate version with semantic advertising and recommendation engine built in;
	The Company expects to be world leaders in semantic technology, by having iGlue to be a unique ‘system’ of several interwoven computational principles the end result of which is the world’s best Web 3.0 technology.
	Basis of presentation
	The accompanying consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the SEC. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America for financial information have been condensed pursuant to such rules and regulations. In the opinion of management, the accompanying financial statements include all adjustments (consisting of normal recurring accruals) considered necessary to make the financial statements not misleading as of and for the periods ended December 31, 2014, December 31, 2013 and for the period from September 19, 2007 (date of inception) to December 31, 2014.

Summary_Of_Significant_Account

Summary Of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	The significant accounting policies adopted in preparation of the financial statements are set out below.
	Use of Estimates:
	The preparation of the financial statements in conformity with (US) GAAP requires management to make estimates, judgments and assumptions that affect amounts reported herein. Management believes that such estimates, judgments and assumptions are reasonable and appropriate. However, due to the inherent uncertainty involved, actual results may differ from those based upon management’s judgments, estimates and assumptions. Critical accounting policies requiring the use of estimates are depreciation and amortization and share-based payments
	Revenue Recognition:
	Sales are recognized when there is evidence of a sales agreement, the delivery of the goods or services has occurred, the sales price is fixed or determinable and collectability is reasonably assured, generally upon shipment of product to customers and transfer of title under standard commercial terms. Sales are measured based on the net amount billed to a customer. Generally there are no formal customer acceptance requirements or further obligations. Customers do not have a general right of return on products shipped therefore no provisions are made for return.
	Accounts Receivable and Allowance for Doubtful Accounts:
	Accounts receivable are stated at historical value, which approximates fair value. The Company does not require collateral for accounts receivable. Accounts receivable are reduced by an allowance for amounts that may be uncollectible in the future. This estimated allowance is determined by considering factors such as length of time accounts are past due, historical experience of write offs, and customers’ financial condition.
	Inventories:
	Inventories are stated at the lower of cost, determined based on weighted average cost or market. Inventories are reduced by an allowance for excess and obsolete inventories based on management’s review of on-hand inventories compared to historical and estimated future sales and usage.
	Fixed assets:
	Fixed assets are stated at cost or fair value for impaired assets. Depreciation and amortization is computed principally by the straight-line method. Asset amortization charges are recorded for long lived assets. In the related periods, no asset impairment charges were accounted for.
	Depreciation is recorded commencing the date the assets are placed in service and is calculated using the straight line basis over their estimated useful lives.
	The estimated useful lives of the various classes of long-lived assets are approximately 3-7 years.
	Pensions and Other Post-retirement Employee benefits:
	In Hungary, pensions are guaranteed and paid by the state or by pension funds, therefore no pensions and other post-retirement employee benefit costs or liabilities are to be calculated and accounted by the Company.
	Product warranty:
	The Company accrues for warranty obligations for products sold based on management estimates, with support from sales, quality and legal functions, of the amount that eventually will be required to settle such obligations. At December 31, 2014, the Company had no warranty obligations.
	Advertising costs:
	Advertising and sales promotion expenses are expensed as incurred.
	Research and development:
	In accordance with ASC 730-10-25 “Accounting for Research and Development Costs,” all research and development (“R&D”) costs are expensed when they are incurred, unless they are reimbursed under specific contracts. Assets used in R&D activity, such as machinery, equipment, facilities and patents that have alternative future use either in R&D activities or otherwise are capitalized.
	Income taxes:
	The Company accounts for income taxes in accordance with ASC 740-10-25, “Accounting for Income Taxes”. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.
	Valuation allowances are provided against deferred tax assets to the extent that it is more likely than not that the deferred tax assets will not be realized.
	Comprehensive Income (Loss):
	ASC 220-10-25, “Accounting for Comprehensive Income,” establishes standards for reporting and disclosure of comprehensive income and its components (including revenues, expenses, gains and losses) in a full set of general-purpose financial statements. The items of other comprehensive income that are typically required to be disclosed are foreign currency items, minimum pension liability adjustments, and unrealized gains and losses on certain investments in debt and equity securities. Accumulated other comprehensive income, at December 31, 2014 is $105,726.
	Translation of Foreign Currencies:
	The U.S. dollar is the functional currency for all of the Company’s businesses, except its operations in Hungary. Foreign currency denominated assets and liabilities for this unit is translated into U.S. dollars based on exchange rates prevailing at the end of each period presented, and revenues and expenses are translated at average exchange rates during the period presented. The effects of foreign exchange gains and losses arising from these translations of assets and liabilities are included as a component of equity, under other comprehensive income.
	Loss per Share:
	Under ASC 260-10-45, “Earnings Per Share”, basic loss per common share is computed by dividing the loss applicable to common stockholders by the weighted average number of common shares assumed to be outstanding during the period of computation. Diluted loss per common share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. At December 31, 2014 and December 31, 2013, respectively, the Company had the following convertible securities outstanding:
		-	The Holder of the Series A Preferred Stock shall have the right, from time to time, commencing on January 1, 2013 and continuing until December 31, 2017, to convert two hundred thousand (200,000) shares of Series A Preferred Stock per calendar year into fully paid and non-assessable shares of Common Stock at the conversion ratio of Three Million (3,000,000) shares of Common Stock for each Two Hundred Thousand (200,000) shares of Series A Preferred Stock.
		-	A total of 4,500,000 Warrant shares are convertible into 4,500,000 shares of common stock.
	Business Segment:
	ASC 280-10-45, “Disclosures About Segments of an Enterprise and Related Information,” establishes standards for the way public enterprises report information about operating segments in annual financial statements and requires reporting of selected information about operating segments in interim financial statements regarding products and services, geographical areas and major customers. The Company has determined that under ASC 280-10-45, there are no operating segments since substantially all business operations, assets and liabilities are in Hungarian geographic segment.
	Recent accounting pronouncements:
	There are no new accounting pronouncements that are applicable to the Company.

Other_Receivables

Other Receivables	12 Months Ended
	Dec. 31, 2014
Receivables [Abstract]
Other Receivables	NOTE 3 - OTHER RECEIVABLES
		December 31,		December 31,
		2014		2013
	Taxes receivable		18,873		26,023
	Deposit given		—		—
	Other		—		—
	Total		18,873		26,023

Intangible_Assets

Intangible Assets	12 Months Ended
	Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	NOTE 4 - INTANGIBLE ASSETS
	Intangibles consisted of the followings at December 31, 2014 and December 31, 2013:
		December 31,			December 31,
		2014			2013
	Rights and software	$	12,979		$	12,979
	Total		12,979			12,979
	Less:		(12,791	)		(12,306	)
	Accumulated amortization
			188			673
	Net intangibles

Fixed_Assets

Fixed Assets	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Fixed Assets	NOTE 5 - FIXED ASSETS
	Net property and equipment consisted of the followings at December 31, 2014 and December 31, 2013:
		December 31,			December 31,
		2014			2013
	Computers and office equipments	$	38,761		$	38,761
	Total		38,761			38,761
	Less:		(38,528	)		(38,246	)
	Accumulated depreciation
	Net property and equipment		233			515

Accounts_Payable_And_Accured_E

Accounts Payable And Accured Expenses	12 Months Ended
	Dec. 31, 2014
Payables and Accruals [Abstract]
Accounts Payable and Accured Expenses	NOTE 6 - ACCOUNTS PAYABLE AND ACCRUED EXPENSES
		December 31,		December 31,
		2014		2013
	Accounts payable	$	10,937	$	72,053
	Accrued expenses		92,600		37,404
	Total		103,537		109,457

Note_Payable

Note Payable	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Note Payable	NOTE 7 - NOTE PAYABLE
	On November 3, 2011, the Company authorized and issued a debenture to the order of Park Slope, LLC.  The debenture must be paid in full by the maturity date and accrued interest on the outstanding amount of the loan at a rate of twelve percent (12%) per annum in one lump sum payable on the maturity date of December 31, 2012. The accrued loan interest amounts to $284,548 at December 31, 2014.
	As such note payable was issued immediately prior to the reverse merger, such issuance was recorded as additional compensation by the Company prior to the reverse merger. Accordingly, such compensation is reflected in the accompanying consolidated balance sheet as the accumulated deficit of the Company, and will not be reflected in the Statement of operations, as such compensation expense was structured as an expense prior to the recapitalization.
	At any time between the original issue date and the maturity date (December 31, 2012) unless previously repaid by the Company, this Debenture shall be convertible into shares of common stock of the Company, par value $0.001 per share, at the option of the holder, in whole or in part. The holder shall effect conversions by delivering to the Company the form of Notice of Conversion specifying therein the amount of the loan plus interest to be converted. The date which the Company receives the Notice of Conversion shall be the conversion date.
	On any conversion date, the loan, or any portion thereof, is convertible into shares of the Company’s common stock at a conversion price equal to the average of the immediately preceding three closing bid prices prior to receipt by the Company of the Notice of Conversion to the Company.
	This Note was extended to December 31, 2015.

Other_Liabilities

Other Liabilities	12 Months Ended
	Dec. 31, 2014
Other Liabilities Disclosure [Abstract]
Other Liabilities	NOTE 8 - OTHER LIABILITIES
		December 31,		December 31,
		2014		2013
	Liabilities to employees	$	329	$	3,611
	Accrued loan interest		284,548		194,548
	Other		53,494		39,131
	Total		338,371		237,290
	Other liabilities include operational funding from owners to improve short term liquidity and settle outstanding payables.

Stockholders_Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2014
Equity [Abstract]
Stockholders' Equity	NOTE 9 - STOCKHOLDERS’ EQUITY
	The proceeds of the following placements related to 2012:
	On June 13, 2012, pursuant to a private placement under Regulation S of the Securities Act of 1933, as amended, the Company sold 21,100 shares of its common stock at $1.00 per share to one unaffiliated private investor for the aggregate amount of $21,100.
	On June 11, 2012, pursuant to a private placement under Regulation S of the Securities Act of 1933, as amended, the Company sold 43,300 shares of its common stock at $1.00 per share to one unaffiliated private investor for the aggregate amount of $43,300.
	On April 4, 2012, pursuant to a private placement under Regulation S of the Securities Act of 1933, as amended, the Company sold 11,312 shares of its common stock at $2.00 per share to one unaffiliated private investor for the aggregate amount of $22,624.
	On April 1, 2012, pursuant to a private placement under Regulation S of the Securities Act of 1933, as amended, the Company sold 22,624 shares of its common stock at $.001 per share to one unaffiliated private investor for the aggregate amount of $22,624.
	During March 2012, pursuant to a private placement under Regulation S of the Securities Act of 1933, as amended, the Company sold 29,251 shares of its common stock at $1.00 per share to two unaffiliated private investors for the aggregate amount of $29,251.
	The proceeds of the following placements were settled as advance in 2011:
	On February 10, 2012, pursuant to a private placement under Regulation S of the Securities Act of 1933, as amended, the Company sold 104,167 shares of its common stock at $1.00 per share to one unaffiliated private investor for the aggregate amount of $104,167.
	On February 10, 2012, pursuant to a private placement under Regulation S of the Securities Act of 1933, as amended, the Company sold 91,138 shares of its common stock at $1.00 per share to one unaffiliated private investor for the aggregate amount of $91,138.
	On February 10, 2012, pursuant to a private placement under Regulation S of the Securities Act of 1933, as amended, the Company sold 43,000 shares of its common stock at $1.00 per share to one unaffiliated private investor for aggregate proceeds of $43,000.
	On February 10, 2012 pursuant to a private placement under Regulation S of the Securities Act of 1933, as amended, the Company sold 185,185 shares of its common stock at $1.00 per share to one unaffiliated private investor for the aggregate amount of $185,185.
	During the year ended December 31, 2012, pursuant to a private placement under Regulation S of the Securities Act of 1933, as amended, there was a total of $138,899 received from private placements. Private placements related to proceeds from six non-affiliated individuals during the first six months of 2012. The total amount comprised of 116,275 pieces of shares sold at $1 per share and 11,312 pieces of shares sold at $2 per share.
	On May 17, 2009 In4 Ltd. received an investment of $550,000 dollars from one accredited, unaffiliated Hungarian investor. As part of the investment agreement In4 Ltd. stipulated an equity buyback option. This option states that the company has an option to repurchases from the investor 4% equity for HUF 132,000,000, which option expires on August 12, 2011. As all parties involved have elected to take the company public this agreement is no longer in effect and in fact has expired on August 12, 2011.
	Stock based compensations
	On June 1, 2012, the Company entered into a restricted stock agreement with Mr. Peter Boros, Chief Executive Officer of the Company. As part of the agreement Mr. Boros was granted 490,000 shares of restricted common stock, of which 250,000 shares vested immediately with the rest vesting in equal installments of 40,000 shares per each closed quarter, commencing with the first quarter of September 30, 2012 and ending on December 31, 2013 or until such date, if it is prior to December 31, 2013, provided Mr. Boros remains employed by the Company.
	On June 1, 2012, the Company entered into a restricted stock agreement with Mr. Viktor Rozsnyay, interim Director of In4, Ltd, our wholly owned subsidiary. As part of the agreement Mr. Rozsnyay was granted 150,000 shares of restricted common stock, all of which vested immediately.
	On June 1, 2012, the Company entered into a restricted stock agreement with Mr. Daniel Kun, Jr., an advisor to the Company. As part of the agreement Mr. Kun was granted 100,000 shares of restricted common stock, all of which vested immediately.
	On June 1, 2012, the Company entered into a restricted stock agreement with Ms. Stella Kun, Executive Assistant to Mr. Boros and Mr. Rozsnyay. As part of the agreement Ms. Kun was granted 56,000 shares of restricted common stock, of which 8,000 shares vested immediately with the rest vesting in equal installments of 8,000 shares per each closed quarter, commencing with the first quarter of September 30, 2012 and ending on December 31, 2013 or until such date, if it is prior to December 31, 2013, provided Ms. Kun remains employed by the Company.
	On February 21, 2012, the Company entered into a restricted stock agreement with Adam Meszaros, Lead Programmer of the Company. As part of the agreement Mr. Meszaros was granted 135,000 shares of restricted common stock, of which 15,000 shares vested immediately with the rest vesting in equal installments of 15,000 shares per each closed quarter, commencing with the first quarter of March 31, 2012 and ending on December 31, 2013 or until such date, if it is prior to December 31, 2013, provided Mr. Meszaros remains employed by the Company. On June 11, 2012 Mr. Meszaros submitted his immediate resignation, therefore forfeiting his unvested shares. Upon his resignation the Company cancelled 105,000 of Mr. Meszaros’ unvested shares.
	On February 21, 2012, the Company entered into a restricted stock agreement with Peter Garas, Lead Server Side Programmer at the Company. As part of the agreement Mr. Garas was granted 54,000 shares of restricted common stock, of which 6,000 shares vested immediately with the rest vesting in equal installments of 6,000 shares per each closed quarter, commencing with the first quarter of March 31, 2012 and ending on December 31, 2013 or until such date, if it is prior to December 31, 2013, provided Mr. Garas remains employed by the Company. On May 31, 2012 Mr. Garas submitted his immediate resignation, therefore forfeiting his unvested shares. Upon his resignation the Company cancelled 42,000 of Mr. Garas’ unvested shares.
	On February 21, 2012, the Company entered into a restricted stock agreement with Janka Barkoczi, Office Manager of the Company. As part of the agreement Ms. Barkoczi was granted 27,000 shares of restricted common stock, of which 3,000 shares vested immediately with the rest vesting in equal installments of 3,000 shares per each closed quarter, commencing with the first quarter of March 31, 2012 and ending on December 31, 2013 or until such date if it is prior to December 31, 2013, provided Ms. Barkoczi remains employed by the Company. On September 11, 2012 Ms. Barkoczi submitted her immediate resignation, therefore forfeiting his unvested shares. Upon his resignation the Company cancelled 18,000 of Ms. Barkoczi’s unvested shares.
	On February 21, 2012, the Company entered into a restricted stock agreement with Eszter Ripka, Arts Director of the Company. As part of the agreement Ms. Ripka was granted 9,000 shares of restricted common stock, of which 1,000 shares vested immediately with the rest vesting in equal installments of 1,000 shares per each closed quarter, commencing with the first quarter of March 31, 2012 and ending on December 31, 2013 or until such date, if it is prior to December 31, 2013, provided Ms. Ripka remains employed by the Company. On September 11, 2012 Ms. Ripka submitted her immediate resignation, therefore forfeiting his unvested shares. Upon his resignation the Company cancelled 6,000 of Ms. Ripka’s unvested shares.
	On February 21, 2012, the Company entered into a restricted stock agreement with Csaba Toth, Arts Director of the Company. As part of the agreement Mr. Toth was granted 9,000 shares of restricted common stock, of which 1,000 shares vested immediately with the rest vesting in equal installments of 1,000 shares per each closed quarter, commencing with the first quarter of March 31, 2012 and ending on December 31, 2013 or until such date, if it is prior to December 31, 2013, provided Mr. Toth remains employed by the Company. On June 20, 2012 Mr. Toth submitted his immediate resignation, therefore forfeiting his unvested shares. Upon his resignation the Company cancelled 7,000 of Mr. Toth’ unvested shares.
	On February 21, 2012, the Company entered into a restricted stock agreement with Gergely Nyikos, Designer at the Company. As part of the agreement Mr. Nyikos was granted 18,000 shares of restricted common stock, of which 2,000 shares vested immediately with the rest vesting in equal installments of 2,000 shares per each closed quarter, commencing with the first quarter of March 31, 2012 and ending on December 31, 2013 or until such date, if it is prior to December 31, 2013, provided Mr. Nyikos remains employed by the Company. On September 30, 2012 Mr. Nyikos submitted her immediate resignation, therefore forfeiting his unvested shares. Upon his resignation the Company cancelled 12,000 of Mr. Nyikos’s unvested shares.
	On February 21, 2012, the Company entered into a restricted stock agreement with Zoltan Annus, Project Manager of the Company. As part of the agreement Mr. Annus was granted 60,000 shares of restricted common stock, of which 6,000 shares vesting in equal installments per each closed quarter, commencing with the first quarter of March 31, 2012 and ending on September 30, 2014 or until such date, if it is prior to September 30, 2014, provided Mr. Annus remains employed by the Company.
	On January 30, 2012, the Company entered into a restricted stock agreement with Zoltán Budy, who is to serve as the Chief Financial Officer of the Company. As part of the agreement Mr. Budy was granted 200,000 shares of the Company’s restricted common stock of which 100,000 shares vest upon execution and 25,000 shares vest quarterly up to December 31, 2012, providing Mr. Budy remains employed by the Company.
	As consideration for the above services, the Company issued an aggregate of 1,133,000 shares of the Company’s common stock. These share issuances were recorded at $9.25, $8.00 and $4.00 per share, respectively, in the total amount of $9,357,750 in accordance with measurement date principles prescribed under FAS 123 (R).
	In June 2012, the Company entered into an agreement with the company of one director for consulting services. According to the agreement the professional provides consulting services to the Company in 2012. In connection with these services, the Company issued to them 15,000 shares of the Company’s common stock. As consideration for such services, the Company issued an aggregate of 15,000 shares of the Company’s common stock. These share issuances were recorded at the fair value of commitment date ($9.25 per share) in the total amount of $138,750 in accordance with measurement date principles prescribed under ASC 505-50 and ASC 718-10. The Company is amortizing the fair value of the shares over the term of the agreement to stock-based compensation expense, which amounted to $0 for the period ended December 31, 2014, respectively and $138,750 for the period from September 19, 2007 (date of inception) to December 31, 2014, in accordance with ASC 505-50 and ASC 718-10.
	Warrants
	On June 11, 2012, the Company issued a Common Stock Purchase Warrant to PDV Consulting, Kft (“PDV”) Under the terms of the warrant, PDV can acquire a total of 1,500,000 shares of our common stock at a per share price of $10.00. The warrant expires on June 12, 2017. The warrants were issued as part of the cost of raising equity.
	The company evaluated the warrants based on essential features that would qualify the warrants as liability. Because the warrants did not include any of the qualifying features, the warrants were classified as equity. As such the Company did not capitalize these warrants because the accounting entries would not have an impact on the financial statements. Instead, the Company will expense these warrant valued at the date of issuance unless these warrants are exercised within one year after the date of issuance.
	As of December 31, 2014, the Company has four common stock purchase warrants each with a term of five years after their issuance date and an exercise price of $5.00, $7.00, $9.00 and $10.00 per share, respectively. The $5.00, $7.00 and $9.00 warrants entitle the holder to purchase from the Company up to 1,000,000 warrant shares each, while the $10.00 warrant holder can acquire up to 1,500,000 shares. As of December 31, 2014 the Company has four Warrants outstanding that are exercisable for an aggregate of up to 4,500,000 shares of its common stock.
	As of December 31, 2014, there were 1,000,000 shares of Series A Preferred Stock issued and outstanding held by the Company’s former President Peter Vasko. Commencing on January 1, 2013, and continuing until December 31, 2017, Mr. Vasko may convert 200,000 shares of Series A Preferred Stock per calendar year into shares of Common Stock at the conversion ratio of 3,000,000 shares of Common Stock for each 200,000 shares of Series A Preferred Stock. Mr. Vasko is entitled to vote together with the holders of the Common Stock and has 42 votes for every share of Series A Preferred Stock held by Mr. Vasko at the time Mr. Vasko may make such a vote.
	The fair value of the liability using Black-Scholes valuation at December 31, 2014 is nil which is classified at short term liabilities. The fair value of the liability is established as a Level 3 fair value measurement.
	Stock split
	On January 15, 2012 the Company performed a reverse stock split detailed in Note 1 above. Additional paid in capital related to private placements made by non affiliated individuals in exchange for subsequent registration subject to the reverse stock split. The placements were made in cash and accounted for as an advance in 2011. The shares were issued in 2012 after the stock split.
	The description of the Series A Preferred Stock does not purport to be complete and is qualified by reference to the full text of Exhibit 4.1 to the Form 8-K filed on November 14, 2011.
	On May 17, 2009 In4 Ltd. received an investment of $550,000 dollars from one accredited, unaffiliated Hungarian investor. As part of the investment agreement In4 Ltd. stipulated an equity buyback option. This option states that the company has an option to repurchases from the investor 4% equity for HUF 132,000,000, which option expires on August 12, 2011. As all parties involved have elected to take the company public this agreement is no longer in effect and in fact has expired on August 12, 2011.
	As of December 31, 2012 the Company has four common stock warrants outstanding that are exercisable for an aggregate of up to 4,500,000 shares of its common stock each with a term of five years after their issuance date. Three warrants entitle the holder to purchase from the Company up to 1,000,000 warrant shares at an exercise price of $5.00, $7.00, $9.00 each and one warrant entitles the holder to purchase up to1.500.000 warrant shares at an exercise price of $10 per share.
	As of February, 2012, there were 1,000,000 shares of Series A Preferred Stock issued and outstanding held by the Chief Executive Officer and sole director, Peter Vasko. Commencing on January 1, 2013, and continuing until December 31, 2017, Mr. Vasko may convert 200,000 shares of Series A Preferred Stock per calendar year into shares of Common Stock at the conversion ratio of 3,000,000 shares of Common Stock for each 200,000 shares of Series A Preferred Stock. Mr. Vasko is entitled to vote together with the holders of the Common Stock and has 42 votes for every share of Series A Preferred Stock held by Mr. Vasko at the time Mr. Vasko may make such vote.
	On January 15, 2012 the Company performed a reverse stock split detailed in Note 1 above. The 886,000 preferred stock was also converted into 8,860,000 common stock.
	Additional paid in capital related to private placements made by non affiliated individuals in exchange for subsequent registration subject to the reverse stock split. The placements were made in cash and accounted for as an advance.

Research_And_Development_RD

Research And Development (''R&D'')	12 Months Ended
	Dec. 31, 2014
Research and Development [Abstract]
Research and Development (''R&D'')	NOTE 10 - RESEARCH AND DEVELOPMENT (“R&D”)
			For the period ended December 31,		For the period ended December 31,
			2014		2013
	Server hosting	$	—	$	—
	Translations		—		—
	Software development		—		—
	Payroll expenses		—		—
	Other		—		—
	Total	$	—	$	—

General_And_Administration

General And Administration	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
General and Administration	NOTE 11 - GENERAL AND ADMINISTRATION
		For the period ended		For the period ended
		31-Dec-14		31-Dec-13
	Material expenses	$	—	$	—
	Stock based compensation		96,000		1,776,000
	Cost of services		15,164		21,927
	Depreciation and amortization		625		2,527
	Other expenses		—		212,834
	Total		111,789		2,013,288

Financial_Expenses_And_Gains_N

Financial Expenses And Gains, Net	12 Months Ended
	Dec. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Financial Expenses and Gains, Net	NOTE 12 - FINANCIAL EXPENSES AND GAINS, NET
		For the period ended			For the period ended
		December 31,			December 31,
		2014			2013
	Interest expense		90,000			90,007
	Interest income		—			—
	Exchange loss, net		(7,963	)		1,432
	Total	$	82,037		$	91,439

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 31, 2014
Subsequent Events [Abstract]
Subsequent Events	NOTE 13 - SUBSEQUENT EVENTS
	None.

General_Information_Policies

General Information (Policies)	12 Months Ended
	Dec. 31, 2014
General Information Policies
Going Concern and Managementbs Plan	Going Concern and Management’s Plan
	The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate the continuation of the Company as a going concern and assume realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred losses from operations since inception. Management anticipates incurring additional losses in 2012. Further, the Company may incur additional losses thereafter, depending on its ability to generate revenues from the licensing or sale of its technologies and products, or to enter into any or a sufficient number of joint ventures. The Company has no revenue to date.
	Since inception through December 31, 2014, the Company had an accumulated deficit of $12,251,834 and net cash used in operations of $1,667,899. However, management of the Company believes that the future funding from the private placement of the Company’s common shares will allow them to continue operations and execute its business plan.
Basis of Presentation	Basis of presentation
	The accompanying consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the SEC. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America for financial information have been condensed pursuant to such rules and regulations. In the opinion of management, the accompanying financial statements include all adjustments (consisting of normal recurring accruals) considered necessary to make the financial statements not misleading as of and for the periods ended December 31, 2014, December 31, 2013 and for the period from September 19, 2007 (date of inception) to December 31, 2014.

Summary_Of_Significant_Account1

Summary Of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Use of Estimates	Use of Estimates:
	The preparation of the financial statements in conformity with (US) GAAP requires management to make estimates, judgments and assumptions that affect amounts reported herein. Management believes that such estimates, judgments and assumptions are reasonable and appropriate. However, due to the inherent uncertainty involved, actual results may differ from those based upon management’s judgments, estimates and assumptions. Critical accounting policies requiring the use of estimates are depreciation and amortization and share-based payments
Revenue Recognition	Revenue Recognition:
	Sales are recognized when there is evidence of a sales agreement, the delivery of the goods or services has occurred, the sales price is fixed or determinable and collectability is reasonably assured, generally upon shipment of product to customers and transfer of title under standard commercial terms. Sales are measured based on the net amount billed to a customer. Generally there are no formal customer acceptance requirements or further obligations. Customers do not have a general right of return on products shipped therefore no provisions are made for return.
Accounts Receivable and Allowance for Doubtful Accounts	Accounts Receivable and Allowance for Doubtful Accounts:
	Accounts receivable are stated at historical value, which approximates fair value. The Company does not require collateral for accounts receivable. Accounts receivable are reduced by an allowance for amounts that may be uncollectible in the future. This estimated allowance is determined by considering factors such as length of time accounts are past due, historical experience of write offs, and customers’ financial condition.
Inventories	Inventories:
	Inventories are stated at the lower of cost, determined based on weighted average cost or market. Inventories are reduced by an allowance for excess and obsolete inventories based on management’s review of on-hand inventories compared to historical and estimated future sales and usage.
Fixed Assets	Fixed assets:
	Fixed assets are stated at cost or fair value for impaired assets. Depreciation and amortization is computed principally by the straight-line method. Asset amortization charges are recorded for long lived assets. In the related periods, no asset impairment charges were accounted for.
	Depreciation is recorded commencing the date the assets are placed in service and is calculated using the straight line basis over their estimated useful lives.
	The estimated useful lives of the various classes of long-lived assets are approximately 3-7 years.
Pensions and Other Post-Retirement Employee Benefits	Pensions and Other Post-retirement Employee benefits:
	In Hungary, pensions are guaranteed and paid by the state or by pension funds, therefore no pensions and other post-retirement employee benefit costs or liabilities are to be calculated and accounted by the Company.
Product Warranty	Product warranty:
	The Company accrues for warranty obligations for products sold based on management estimates, with support from sales, quality and legal functions, of the amount that eventually will be required to settle such obligations. At December 31, 2014, the Company had no warranty obligations.
Advertising Costs	Advertising costs:
	Advertising and sales promotion expenses are expensed as incurred.
Research and Development	Research and development:
	In accordance with ASC 730-10-25 “Accounting for Research and Development Costs,” all research and development (“R&D”) costs are expensed when they are incurred, unless they are reimbursed under specific contracts. Assets used in R&D activity, such as machinery, equipment, facilities and patents that have alternative future use either in R&D activities or otherwise are capitalized.
Income Taxes	Income taxes:
	The Company accounts for income taxes in accordance with ASC 740-10-25, “Accounting for Income Taxes”. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.
	Valuation allowances are provided against deferred tax assets to the extent that it is more likely than not that the deferred tax assets will not be realized.
Comprehensive Income (Loss)	Comprehensive Income (Loss):
	ASC 220-10-25, “Accounting for Comprehensive Income,” establishes standards for reporting and disclosure of comprehensive income and its components (including revenues, expenses, gains and losses) in a full set of general-purpose financial statements. The items of other comprehensive income that are typically required to be disclosed are foreign currency items, minimum pension liability adjustments, and unrealized gains and losses on certain investments in debt and equity securities. Accumulated other comprehensive income, at December 31, 2014 is $105,726.
Translation of Foreign Currencies	Translation of Foreign Currencies:
	The U.S. dollar is the functional currency for all of the Company’s businesses, except its operations in Hungary. Foreign currency denominated assets and liabilities for this unit is translated into U.S. dollars based on exchange rates prevailing at the end of each period presented, and revenues and expenses are translated at average exchange rates during the period presented. The effects of foreign exchange gains and losses arising from these translations of assets and liabilities are included as a component of equity, under other comprehensive income.
Loss Per Share	Loss per Share:
	Under ASC 260-10-45, “Earnings Per Share”, basic loss per common share is computed by dividing the loss applicable to common stockholders by the weighted average number of common shares assumed to be outstanding during the period of computation. Diluted loss per common share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. At December 31, 2014 and December 31, 2013, respectively, the Company had the following convertible securities outstanding:
		-	The Holder of the Series A Preferred Stock shall have the right, from time to time, commencing on January 1, 2013 and continuing until December 31, 2017, to convert two hundred thousand (200,000) shares of Series A Preferred Stock per calendar year into fully paid and non-assessable shares of Common Stock at the conversion ratio of Three Million (3,000,000) shares of Common Stock for each Two Hundred Thousand (200,000) shares of Series A Preferred Stock.
		-	A total of 4,500,000 Warrant shares are convertible into 4,500,000 shares of common stock.
Business Segment	Business Segment:
	ASC 280-10-45, “Disclosures About Segments of an Enterprise and Related Information,” establishes standards for the way public enterprises report information about operating segments in annual financial statements and requires reporting of selected information about operating segments in interim financial statements regarding products and services, geographical areas and major customers. The Company has determined that under ASC 280-10-45, there are no operating segments since substantially all business operations, assets and liabilities are in Hungarian geographic segment.
Recent Accounting Pronouncements	Recent accounting pronouncements:
	There are no new accounting pronouncements that are applicable to the Company.

Other_Receivables_Tables

Other Receivables (Tables)	12 Months Ended
	Dec. 31, 2014
Receivables [Abstract]
Schedule of Other Receivables		December 31,		December 31,
		2014		2013
	Taxes receivable		18,873		26,023
	Deposit given		—		—
	Other		—		—
	Total		18,873		26,023

Intangible_Assets_Tables

Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	Intangibles consisted of the followings at December 31, 2014 and December 31, 2013:
		December 31,			December 31,
		2014			2013
	Rights and software	$	12,979		$	12,979
	Total		12,979			12,979
	Less:		(12,791	)		(12,306	)
	Accumulated amortization
			188			673
	Net intangibles

Fixed_Assets_Tables

Fixed Assets (Tables)	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Schedule of Fixed Assets	Net property and equipment consisted of the followings at December 31, 2014 and December 31, 2013:
		December 31,			December 31,
		2014			2013
	Computers and office equipments	$	38,761		$	38,761
	Total		38,761			38,761
	Less:		(38,528	)		(38,246	)
	Accumulated depreciation
	Net property and equipment		233			515

Accounts_Payable_And_Accrued_E

Accounts Payable And Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2014
Accounts Payable And Accrued Expenses Tables
Schedule of Accounts Payable and Accrued Expenses
		December 31,		December 31,
		2014		2013
	Accounts payable	$	10,937	$	72,053
	Accrued expenses		92,600		37,404
	Total		103,537		109,457

Other_Liabilities_Tables

Other Liabilities (Tables)	12 Months Ended
	Dec. 31, 2014
Other Liabilities Tables
Schedule of Other Liabilities		December 31,		December 31,
		2014		2013
	Liabilities to employees	$	329	$	3,611
	Accrued loan interest		284,548		194,548
	Other		53,494		39,131
	Total		338,371		237,290

Research_And_Development_RD_Ta

Research And Development (R&D) (Tables)	12 Months Ended
	Dec. 31, 2014
Research And Development Rd Tables
Schedule of Research and Development Expenses			For the period ended December 31,		For the period ended December 31,
			2014		2013
	Server hosting	$	—	$	—
	Translations		—		—
	Software development		—		—
	Payroll expenses		—		—
	Other		—		—
	Total	$	—	$	—

General_And_Administration_Tab

General And Administration (Tables)	12 Months Ended
	Dec. 31, 2014
General And Administration Tables
Schedule of General and Administration Expense		For the period ended		For the period ended
		31-Dec-14		31-Dec-13
	Material expenses	$	—	$	—
	Stock based compensation		96,000		1,776,000
	Cost of services		15,164		21,927
	Depreciation and amortization		625		2,527
	Other expenses		—		212,834
	Total		111,789		2,013,288

Financial_Expenses_And_Gains_N1

Financial Expenses And Gains, Net (Tables)	12 Months Ended
	Dec. 31, 2014
Financial Expenses And Gains Net Tables
Schedule of Financial Expenses and Gains, Net		For the period ended			For the period ended
		December 31,			December 31,
		2014			2013
	Interest expense		90,000			90,007
	Interest income		—			—
	Exchange loss, net		(7,963	)		1,432
	Total	$	82,037		$	91,439

Other_Receivables_Details

Other Receivables (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Other Receivables Details
Taxes receivable	$18,873	$26,023
Deposit given
Other
Total	$18,873	$26,023

Intangible_Assets_Details

Intangible Assets (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Intangible Assets Details
Rights and software	$12,979	$12,979
Total	12,979	12,979
Less: Accumulated amortization	12,791	12,306
Net intangibles	$188	$673

Fixed_Assets_Details

Fixed Assets (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Fixed Assets Details
Computers and office equipments	$38,761	$38,761
Total	38,761	38,761
Less: Accumulated depreciation	38,528	38,246
Net property and equipment	$233	$515

Accounts_Payable_And_Accrued_E1

Accounts Payable And Accrued Expenses (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Accounts Payable And Accrued Expenses Details
Accounts payable	$10,937	$72,053
Accrued expenses	92,600	37,404
Total	$103,537	$109,457

Other_Liabilities_Details

Other Liabilities (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Other Liabilities Details
Liabilities to employees	$329	$3,611
Accrued loan interest	284,548	194,548
Other	53,494	39,131
Total	$338,371	$237,290

Research_And_Development_RD_De

Research And Development (R&D) (Details) (USD $)	12 Months Ended		87 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014
Research And Development Rd Details
Server hosting
Translations
Software development
Payroll expenses
Other
Total			$2,051,802

General_And_Administration_Det

General And Administration (Details) (USD $)	12 Months Ended		87 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014
General And Administration Details
Material expenses
Stock based compensation	96,000	1,776,000
Cost of services	15,164	21,927
Depreciation and amortization	625	2,527	53,008
Other expenses		212,834
Total	$111,789	$2,013,288	$9,137,112

Financial_Expenses_And_Gains_N2

Financial Expenses And Gains, Net (Details) (USD $)	12 Months Ended		87 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014
Financial Expenses And Gains Net Details
Interest expense	$90,000	$90,007
Interest income
Exchange gains, net	7,963	-1,432
Total	($82,037)	($91,439)	($302,920)

General_Information_Narrative_

General Information (Narrative) (Details) (USD $)	0 Months Ended
	Jan. 15, 2012	Nov. 11, 2011
Change in common stock issued and outstanding, shares	1,375,293
Change in capital structure in relation to reverse stock split	Resulting in a reduction of the issued and outstanding number shares from 151,282,223 to 1,375,293, with corresponding increase of par values from $0.001 to $0.11.
Reverse stock split ratio	0.118055556
In4 Ltd
Acquisition Percentage		100.00%
In4 Ltd | Series A Preferred Stock
No. of shares issued in aquisition of business		1,000,000
Business acquisition share price		$0.00
In4 Ltd | Series B Preferred Stock
No. of shares issued in aquisition of business		886,000
Business acquisition share price		$0.00

Summary_Of_Significant_Account2

Summary Of Significant Accounting Policies (Fixed Assets) (Narrative) (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Warrant
Warrants conversion terms	A total of 4,500,000 Warrant shares are convertible into 4,500,000 shares of common stock.	A total of 4,500,000 Warrant shares are convertible into 4,500,000 shares of common stock.
Series A Preferred Stock
Preferred stock conversion terms	The Holder of the Series A Preferred Stock shall have the right, from time to time, commencing on January 1, 2013 and continuing until December 31, 2017, to convert two hundred thousand (200,000) shares of Series A Preferred Stock per calendar year into fully paid and non-assessable shares of Common Stock at the conversion ratio of Three Million (3,000,000) shares of Common Stock for each Two Hundred Thousand (200,000) shares of Series A Preferred Stock.	The Holder of the Series A Preferred Stock shall have the right, from time to time, commencing on January 1, 2013 and continuing until December 31, 2017, to convert two hundred thousand (200,000) shares of Series A Preferred Stock per calendar year into fully paid and non-assessable shares of Common Stock at the conversion ratio of Three Million (3,000,000) shares of Common Stock for each Two Hundred Thousand (200,000) shares of Series A Preferred Stock.
Minimum
Estimated useful lives of the various classes of long-lived assets	3 years
Maximum
Estimated useful lives of the various classes of long-lived assets	7 years

Notes_Payable_Narrative_Detail

Notes Payable (Narrative) (Details) (Notes Payable to Park Slope, LLC, USD $)	0 Months Ended
	Nov. 03, 2011	Dec. 31, 2014
Notes Payable to Park Slope, LLC
Debt Instrument [Line Items]
Rate of interest on loans, percentage	12.00%
Debt instrutment maturity date	31-Dec-12
Extended debt maturity date	31-Dec-15
Accured loan interest		$284,548
Debt conversion terms	At any time between the original issue date and the maturity date (December 31, 2012) unless previously repaid by the Company, this Debenture shall be convertible into shares of common stock of the Company, par value $0.001 per share, at the option of the holder, in whole or in part. The holder shall effect conversions by delivering to the Company the form of Notice of Conversion specifying therein the amount of the loan plus interest to be converted. The date which the Company receives the Notice of Conversion shall be the conversion date.

Stockholders_Equity_Private_Pl

Stockholder's Equity (Private Placements) (Narrative) (Details) (Common Stock, USD $)	0 Months Ended				1 Months Ended	0 Months Ended	12 Months Ended	6 Months Ended
	Jun. 13, 2012	Jun. 11, 2012	Apr. 04, 2012	Apr. 01, 2012	Mar. 31, 2012	Feb. 10, 2012	Dec. 31, 2012	Jun. 30, 2012
Private Placement on June 13, 2012 to One Unaffiliated Private Investor
Subsidiary, Sale of Stock [Line Items]
Common stock issued for private placement	21,100
Share issue price	$1
Proceeds from stock issue	$21,100
Sale of stock transaction date	13-Jun-12
Private Placement to One Unaffiliated Private Investor, June 11, 2012
Subsidiary, Sale of Stock [Line Items]
Common stock issued for private placement		43,300
Share issue price		$1
Proceeds from stock issue		43,300
Sale of stock transaction date		11-Jun-12
Private Placement to One Unaffiliated Private Investor, April 4, 2012
Subsidiary, Sale of Stock [Line Items]
Common stock issued for private placement			11,312
Share issue price			$2
Proceeds from stock issue			22,624
Sale of stock transaction date			4-Apr-12
Private Placement to One Unaffiliated Private Investor, April 1, 2012
Subsidiary, Sale of Stock [Line Items]
Common stock issued for private placement				22,624
Share issue price				$0.00
Proceeds from stock issue				22,624
Sale of stock transaction date				1-Apr-12
Private Placement to Two Unaffiliated Private Investor, March, 2012
Subsidiary, Sale of Stock [Line Items]
Common stock issued for private placement					29,251
Share issue price					$1
Proceeds from stock issue					29,251
Private Placement to One Unaffiliated Private Investor, February 10, 2012
Subsidiary, Sale of Stock [Line Items]
Common stock issued for private placement						104,167
Share issue price						$1
Proceeds from stock issue						104,167
Sale of stock transaction date						10-Feb-12
Private Placement to One Unaffiliated Private Investor, February 10, 2012
Subsidiary, Sale of Stock [Line Items]
Common stock issued for private placement						91,138
Share issue price						$1
Proceeds from stock issue						91,138
Sale of stock transaction date						10-Feb-12
Private Placement to One Unaffiliated Private Investor, February 10, 2012
Subsidiary, Sale of Stock [Line Items]
Common stock issued for private placement						43,000
Share issue price						$1
Proceeds from stock issue						43,000
Sale of stock transaction date						10-Feb-12
Private Placement to One Unaffiliated Private Investor, February 10, 2012
Subsidiary, Sale of Stock [Line Items]
Common stock issued for private placement						185,185
Share issue price						$1
Proceeds from stock issue						185,185
Sale of stock transaction date						10-Feb-12
Private Placement to Six non - affiliated at USD One and Two per share
Subsidiary, Sale of Stock [Line Items]
Proceeds from stock issue							$138,899
Private Placement to Six non - affiliated at USD One per share
Subsidiary, Sale of Stock [Line Items]
Common stock issued for private placement								116,275
Share issue price								$1
Private Placement to Six non - affiliated at USD Two per share
Subsidiary, Sale of Stock [Line Items]
Common stock issued for private placement								11,312
Share issue price								$2

Stockholders_Equity_Stock_Base

Stockholder's Equity (Stock Based Compensation) (Narrative) (Details) (USD $)

12 Months Ended

87 Months Ended

1 Months Ended

0 Months Ended

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2014

Jun. 30, 2012

Jun. 01, 2012

Jun. 11, 2012

Feb. 21, 2012

31-May-12

Sep. 11, 2012

Jun. 20, 2012

Sep. 30, 2012

Jan. 30, 2012

Stock based compensation value

Stock based compensation

96,000

1,968,000

7,293,750

9,357,750

Common Stock

Stock based compensation value

13,420

Director | Common Stock

Common stock issued for service, share

15,000

Share issue price

$9.25

Common stock issued for service, value

138,750

Stock based compensation

0

138,750

Restricted Stock

Stock based compensation share issued

1,133,000

Share issuance prices

These share issuances were recorded at $9.25, $8.00 and $4.00 per share

Stock based compensation value

$9,357,750

Restricted Stock | Mr Peter Boros, Restricted Stock Agreement On June 1, 2012

Shares granted

490,000

Shares vested on grant

250,000

Shares vesting terms

The rest vesting in equal installments of 40,000 shares per each closed quarter, commencing with the first quarter of September 30, 2012 and ending on December 31, 2013 or until such date, if it is prior to December 31, 2013, provided Mr. Boros remains employed by the Company.

Restricted Stock | Mr Viktor Rozsnyay, Restricted Stock Agreement On June 1, 2012

Shares granted

150,000

Shares vested on grant

150,000

Restricted Stock | Mr Daniel Kun, Restricted Stock Agreement On June 1, 2012

Shares granted

100,000

Shares vested on grant

100,000

Restricted Stock | Ms Stella Kun, Restricted Stock Agreement On June 1, 2012

Shares granted

56,000

Shares vested on grant

8,000

Shares vesting terms

The rest vesting in equal installments of 8,000 shares per each closed quarter, commencing with the first quarter of September 30, 2012 and ending on December 31, 2013 or until such date, if it is prior to December 31, 2013, provided Ms. Kun remains employed by the Company.

Restricted Stock | Adam Meszaros, Restricted Stock Agreement On February 21, 2012

Shares granted

135,000

Shares vested on grant

15,000

Shares vesting terms

The rest vesting in equal installments of 15,000 shares per each closed quarter, commencing with the first quarter of March 31, 2012 and ending on December 31, 2013 or until such date, if it is prior to December 31, 2013, provided Mr. Meszaros remains employed by the Company.

Cancellation of unvested shares

105,000

Restricted Stock | Peter Garas, Restricted Stock Agreement On February 21, 2012

Shares granted

54,000

Shares vested on grant

6,000

Shares vesting terms

The rest vesting in equal installments of 6,000 shares per each closed quarter, commencing with the first quarter of March 31, 2012 and ending on December 31, 2013 or until such date, if it is prior to December 31, 2013, provided Mr. Garas remains employed by the Company.

Cancellation of unvested shares

42,000

Restricted Stock | Barkoczi, Restricted Stock Agreement On February 21, 2012

Shares granted

27,000

Shares vested on grant

3,000

Shares vesting terms

The rest vesting in equal installments of 3,000 shares per each closed quarter, commencing with the first quarter of March 31, 2012 and ending on December 31, 2013 or until such date if it is prior to December 31, 2013, provided Ms. Barkoczi remains employed by the Company.

Cancellation of unvested shares

18,000

Restricted Stock | Eszter Ripka, Restricted Stock Agreement On February 21, 2012

Shares granted

9,000

Shares vested on grant

1,000

Shares vesting terms

The rest vesting in equal installments of 1,000 shares per each closed quarter, commencing with the first quarter of March 31, 2012 and ending on December 31, 2013 or until such date, if it is prior to December 31, 2013, provided Ms. Ripka remains employed by the Company.

Cancellation of unvested shares

6,000

Restricted Stock | Csaba Toth, Restricted Stock Agreement On February 21, 2012

Shares granted

9,000

Shares vested on grant

1,000

Shares vesting terms

The rest vesting in equal installments of 1,000 shares per each closed quarter, commencing with the first quarter of March 31, 2012 and ending on December 31, 2013 or until such date, if it is prior to December 31, 2013, provided Mr. Toth remains employed by the Company.

Cancellation of unvested shares

7,000

Restricted Stock | Gergely Nyikos, Restricted Stock Agreement On February 21, 2012

Shares granted

18,000

Shares vested on grant

2,000

Shares vesting terms

The rest vesting in equal installments of 2,000 shares per each closed quarter, commencing with the first quarter of March 31, 2012 and ending on December 31, 2013 or until such date, if it is prior to December 31, 2013, provided Mr. Nyikos remains employed by the Company.

Cancellation of unvested shares

12,000

Restricted Stock | Zoltan Annus, Restricted Stock Agreement On February 21, 2012

Shares granted

60,000

Shares vesting terms

6,000 shares vesting in equal installments per each closed quarter, commencing with the first quarter of March 31, 2012 and ending on September 30, 2014 or until such date, if it is prior to September 30, 2014, provided Mr. Annus remains employed by the Company.

Restricted Stock | Zoltan Budy, Restricted Stock Agreement On January 30, 2012

Shares granted

200,000

Shares vested on grant

100,000

Shares vesting terms

25,000 shares vest quarterly up to December 31, 2012, providing Mr. Budy remains employed by the Company.

Stockholders_Equity_Warrants_N

Stockholder's Equity (Warrants) (Narrative) (Details) (USD $)	12 Months Ended		0 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Jun. 11, 2012
Series A Preferred Stock
Series A preferred stock issued and outstanding	1,000,000	1,000,000
Preferred stock conversion terms	The Holder of the Series A Preferred Stock shall have the right, from time to time, commencing on January 1, 2013 and continuing until December 31, 2017, to convert two hundred thousand (200,000) shares of Series A Preferred Stock per calendar year into fully paid and non-assessable shares of Common Stock at the conversion ratio of Three Million (3,000,000) shares of Common Stock for each Two Hundred Thousand (200,000) shares of Series A Preferred Stock.	The Holder of the Series A Preferred Stock shall have the right, from time to time, commencing on January 1, 2013 and continuing until December 31, 2017, to convert two hundred thousand (200,000) shares of Series A Preferred Stock per calendar year into fully paid and non-assessable shares of Common Stock at the conversion ratio of Three Million (3,000,000) shares of Common Stock for each Two Hundred Thousand (200,000) shares of Series A Preferred Stock.
Series A Preferred Stock | Peter Vasko - Former President
Preferred stock conversion terms	Commencing on January 1, 2013, and continuing until December 31, 2017, Mr. Vasko may convert 200,000 shares of Series A Preferred Stock per calendar year into shares of Common Stock at the conversion ratio of 3,000,000 shares of Common Stock for each 200,000 shares of Series A Preferred Stock.
Preferred stock voting rights	Mr. Vasko is entitled to vote together with the holders of the Common Stock and has 42 votes for every share of Series A Preferred Stock held by Mr. Vasko at the time Mr. Vasko may make such vote.
Warrants
Warrants expiration	5 years
Warrants outstanding, shares	4,500,000
Warrants | Exercise Price - USD Five Per Share
Warrant shares	1,000,000
Warrant share issue price	5
Warrants | Exercise Price - USD Seven Per Share
Warrant shares	1,000,000
Warrant share issue price	7
Warrants | Exercise Price - USD Nine Per Share
Warrant shares	1,000,000
Warrant share issue price	9
Warrants | Exercise Price - USD Ten Per Share
Warrant shares	1,500,000
Warrant share issue price	10
PDV Consulting, Kft ("PDV") | Warrants
Warrant shares			1,500,000
Warrant share issue price			$10
Warrant expiration date			12-Jun-07

Stockholders_Equity_Stock_Spli

Stockholder's Equity (Stock Split) (Narrative) (Details)	Jan. 15, 2012	17-May-09	17-May-09
		In4 Ltd	In4 Ltd
		USD ($)	HUF Currency
			HUF
Investment from accredited, Unaffiliated Hungarian		$550,000
Conversion of preferred stock to common stock	8,860,000
Eqyity buyback option expiry date		12-Aug-11
Equity buyback option percentage		4.00%
Equity buyback value			132,000,000